Are children treated with second-generation antipsychotics at higher risk of weight gain than adults?
Publication date: | 2016 |
Publisher version: | http://doi.org/10.1016/S0924-977X(16)31893-4 |
Description: |
Congress of the European-College-of-Neuropsychopharmacology (29th. 2017. Viena) |
Patrocinado por: |
This work has been supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, co-financed by ERDF Funds from the European Commission, “A way of making Europe”, CIBERSAM, Madrid Regional Government (S2010/BMD-2422 AGES), European Union Structural Funds and European Union Seventh Framework Program under grant agreements FP7-HEALTH-2009−2.2.1−2–241909 (Project EUGEI),FP7-HEALTH-2009−2.2.1−3–242114 (Project OPTiMISE), FP7-HEALTH-2013−2.2.1−2–603196 (Project PSYSCAN), FP7-HEALTH- 2013−2.2.1−2–602478 (Project METSY) and FP7-HEALTH- F4–2010–241959 (Project PERS) Fundación Alicia Koplowitz and Fundación Mutua Madrileña. C.M. Díaz-Caneja has held a grant Río Hortega, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness and from Fundación Alicia Koplowitz |
Id. Proyecto: |
S2010/BMD-2422 AGES FP7-HEALTH-2009−2.2.1−2–241909 FP7-HEALTH-2009−2.2.1−3–24211 FP7-HEALTH-2013−2.2.1−2–603196 FP7-HEALTH-2013−2.2.1−2–602478 FP7-HEALTH- F4–2010–241959 |
